DE69818255D1 - Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind - Google Patents

Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind

Info

Publication number
DE69818255D1
DE69818255D1 DE69818255T DE69818255T DE69818255D1 DE 69818255 D1 DE69818255 D1 DE 69818255D1 DE 69818255 T DE69818255 T DE 69818255T DE 69818255 T DE69818255 T DE 69818255T DE 69818255 D1 DE69818255 D1 DE 69818255D1
Authority
DE
Germany
Prior art keywords
aryl
substituted piperazines
piperazines useful
hyperlasia
prostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69818255T
Other languages
English (en)
Other versions
DE69818255T2 (de
Inventor
Linda Jolliffe
William Murray
Virginia Pulito
Alan Reitz
Xiaobing Li
Linda Mulcahy
Cynthia Maryanoff
Frank Villani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE69818255D1 publication Critical patent/DE69818255D1/de
Application granted granted Critical
Publication of DE69818255T2 publication Critical patent/DE69818255T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69818255T 1997-05-12 1998-05-08 Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind Expired - Fee Related DE69818255T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4623697P 1997-05-12 1997-05-12
US46236 1997-05-12
PCT/US1998/009023 WO1998051298A1 (en) 1997-05-12 1998-05-08 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia

Publications (2)

Publication Number Publication Date
DE69818255D1 true DE69818255D1 (de) 2003-10-23
DE69818255T2 DE69818255T2 (de) 2004-12-23

Family

ID=21942353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69818255T Expired - Fee Related DE69818255T2 (de) 1997-05-12 1998-05-08 Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind

Country Status (28)

Country Link
US (4) US6071915A (de)
EP (1) EP0984777B1 (de)
JP (1) JP4189867B2 (de)
KR (1) KR100440755B1 (de)
CN (3) CN1515556A (de)
AP (1) AP1349A (de)
AR (1) AR012686A1 (de)
AT (1) ATE250033T1 (de)
AU (1) AU7366998A (de)
BR (1) BR9809804A (de)
CA (1) CA2289987C (de)
CZ (1) CZ298217B6 (de)
DE (1) DE69818255T2 (de)
DK (1) DK0984777T3 (de)
EA (1) EA001904B1 (de)
ES (1) ES2206928T3 (de)
HK (1) HK1024630A1 (de)
HU (1) HUP0100048A3 (de)
IL (1) IL132836A0 (de)
MY (2) MY127385A (de)
NO (1) NO314144B1 (de)
NZ (1) NZ500992A (de)
PL (1) PL192596B1 (de)
PT (1) PT984777E (de)
TR (1) TR199902971T2 (de)
TW (1) TW512146B (de)
WO (1) WO1998051298A1 (de)
ZA (1) ZA983968B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768055A1 (fr) * 1997-09-11 1999-03-12 Synthelabo Utilisation de derives de sulfonanilide pour obtenir un medicament destine au traitement de l'ejaculation retrograde ou de l'aspermie
TW536538B (en) 1998-02-20 2003-06-11 Ortho Mcneil Pharm Inc Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
ZA991319B (en) * 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
EP1346983A3 (de) * 1998-02-20 2003-12-03 Ortho-Mcneil Pharmaceutical, Inc. Phthalimido-arylpiperazine als alpha 1A Rezeptor Antagonisten nützlich zur Behandlung von gutartiger Prostatahyperplasie
WO2002022582A2 (en) * 2000-09-14 2002-03-21 Ortho-Mcneil Pharmaceutical, Inc. Solid salt forms of n-[2-[4-[2-(1-methylethoxy)phenyl]-1-piperazinyl]ethyl]-2-oxo-1-piperidineacetamide
MXPA03004850A (es) 2000-11-30 2004-01-26 Ranbaxy Lab Ltd Derivados de piperazina 1,4-disustituida utiles como bloqueadores de alfa1 adrenoceptores uro-selectivos.
WO2005118537A2 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Arylpiperazine derivatives as adrenergic receptor antagonists
WO2006092710A1 (en) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione
WO2007029156A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Isoindoledione derivatives as adrenergic receptor antagonists
CN102391169B (zh) * 2011-10-17 2015-10-28 上海化学试剂研究所 N-(5-甲氧基-3-吲哚乙基)-4-取代苯基哌嗪-1-乙酰胺的制备方法
CN103387531A (zh) * 2012-05-10 2013-11-13 广州医学院 酰胺类芳基哌嗪衍生物及其制备方法和在抗良性***增生中的应用
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性***增生症药物中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069336A (en) * 1976-02-25 1978-01-17 Chemisches Laboratorium Fritz-Walter Lange Gmbh & Co Kg (2-oxo-pyrrolidines)-acetic hydrazides
JPS5955878A (ja) 1982-09-24 1984-03-31 Chugai Pharmaceut Co Ltd 新規なフエニルピペラジン誘導体
AU1475583A (en) * 1983-04-27 1984-11-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituted picolinic acids, processes for their preparation,their use and medicaments containing them
JPS62135464A (ja) * 1985-12-10 1987-06-18 Nippon Kayaku Co Ltd フエニルピペラジン誘導体
GB8703749D0 (en) 1987-02-18 1987-03-25 Sandoz Ltd Piperazinecarboxylic acid
US5254552A (en) * 1988-05-24 1993-10-19 American Home Products Corporation Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
EP0558245A1 (de) * 1992-02-25 1993-09-01 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Heterobicyclische Verbindungen als Alpha-1-Adrenergene und 5HT1A-Rezeptor-Antagonisten
FR2692894B1 (fr) * 1992-06-24 1994-10-14 Irceba Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments.
US5403847A (en) * 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
US5807856A (en) * 1995-11-15 1998-09-15 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonist
EP0881235A1 (de) * 1997-05-26 1998-12-02 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Phosphor Ylide, Herstellung und Verwendung zu schwachnukleophilen starkbasischen Verbindungen
TW536538B (en) * 1998-02-20 2003-06-11 Ortho Mcneil Pharm Inc Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
US6218396B1 (en) * 1998-02-20 2001-04-17 Orth-Mcneil Pharmaceutical, Inc. Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
US6063785A (en) * 1999-02-17 2000-05-16 Ortho-Mcneil Pharmaceutical Inc. Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia

Also Published As

Publication number Publication date
ZA983968B (en) 1999-11-11
KR20010012505A (ko) 2001-02-15
WO1998051298A1 (en) 1998-11-19
NO314144B1 (no) 2003-02-03
CA2289987C (en) 2006-03-14
EP0984777A4 (de) 2001-04-25
AP1349A (en) 2004-12-17
US20030220493A1 (en) 2003-11-27
IL132836A0 (en) 2001-03-19
JP4189867B2 (ja) 2008-12-03
DK0984777T3 (da) 2003-12-08
NO995518D0 (no) 1999-11-11
NZ500992A (en) 2003-02-28
HUP0100048A2 (hu) 2001-07-30
AP9901684A0 (en) 1999-12-31
CN1515556A (zh) 2004-07-28
CN1149081C (zh) 2004-05-12
CN1269807C (zh) 2006-08-16
CZ298217B6 (cs) 2007-07-25
US6890921B1 (en) 2005-05-10
AU7366998A (en) 1998-12-08
PT984777E (pt) 2004-01-30
BR9809804A (pt) 2000-06-27
JP2002511065A (ja) 2002-04-09
TW512146B (en) 2002-12-01
PL342518A1 (en) 2001-06-18
US6071915A (en) 2000-06-06
HUP0100048A3 (en) 2002-12-28
NO995518L (no) 2000-01-11
CZ399799A3 (cs) 2000-04-12
MY122095A (en) 2006-03-31
ATE250033T1 (de) 2003-10-15
CA2289987A1 (en) 1998-11-19
KR100440755B1 (ko) 2004-07-21
EA001904B1 (ru) 2001-10-22
DE69818255T2 (de) 2004-12-23
EP0984777B1 (de) 2003-09-17
CN1515563A (zh) 2004-07-28
TR199902971T2 (xx) 2001-03-21
MY127385A (en) 2006-11-30
US6593474B1 (en) 2003-07-15
ES2206928T3 (es) 2004-05-16
CN1264300A (zh) 2000-08-23
EP0984777A1 (de) 2000-03-15
AR012686A1 (es) 2000-11-08
PL192596B1 (pl) 2006-11-30
HK1024630A1 (en) 2000-10-20
EA199900928A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
DE69807476D1 (de) Behandlung von schweren aromaten
DE69008048D1 (de) Duftzusammensetzungen und ihre Verwendung in Reinigungsmitteln.
ID18993A (id) Pakaian dalam harum
DE59506473D1 (de) Tensidgemische
ID24663A (id) Turunan-turunan piperazin
DE69839775D1 (de) Kondensatoren in integrierten schaltkreisen
DE59508648D1 (de) Milde detergensgemische
DE69522117D1 (de) Waschmittelzusammensetzung und waschverfahren
DE69530815D1 (de) Viskosimeter
DE69818255D1 (de) Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind
DE69528621D1 (de) Multifokallinse
FR2717684B1 (fr) Compositions cosmétiques détergentes et utilisations.
DE59810482D1 (de) Schleifen von garnituren
DE59503545D1 (de) Computergestützte umwandlung von tabellen
DE59707351D1 (de) Schleifen von Garnituren
DE59505049D1 (de) Milde detergensgemische
DE69508894D1 (de) Reinigung von propofol
DE69821636D1 (de) Alkoxylierte amine und ihre verwendung in reinigungsmitteln
KR960003763U (ko) 가방밑판
DE59908316D1 (de) Schleifen von garnituren
DE59505462D1 (de) Recyclefähige schleifkörperzonen
DE59505312D1 (de) Milde detergensgemische
DE59500653D1 (de) Gleichstrom-Sparschaltung
DE59507095D1 (de) Verwendung von detergensgemischen
KR960013064U (ko) 구멍뚫린 두부

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee